Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 2
2008 4
2009 4
2010 4
2011 7
2012 5
2013 1
2014 2
2015 7
2016 5
2017 6
2018 1
2019 6
2020 8
2021 8
2022 10
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment.
Morimoto Y, Fushimi A, Yamashita N, Hagiwara M, Bhattacharya A, Cheng J, Frost TC, Ahmad R, Daimon T, Huang L, Hata T, Takahashi H, Yamamoto M, Suzuki Y, DeCaprio JA, Kufe D. Morimoto Y, et al. Among authors: ahmad r. Oncogene. 2022 Jul;41(27):3511-3523. doi: 10.1038/s41388-022-02361-3. Epub 2022 Jun 10. Oncogene. 2022. PMID: 35688945 Free PMC article.
Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders.
Ahmad SR, Zeyaullah M, AlShahrani AM, Dawria A, Ali H, Mohieldin A, Altijani AA, Razi U, Mehdi M, Akram S, Hussain ER. Ahmad SR, et al. Front Biosci (Landmark Ed). 2024 Apr 8;29(4):142. doi: 10.31083/j.fbl2904142. Front Biosci (Landmark Ed). 2024. PMID: 38682185 Free article. Review.
Primary, secondary, and tertiary hyperparathyroidism.
Ahmad R, Hammond JM. Ahmad R, et al. Otolaryngol Clin North Am. 2004 Aug;37(4):701-13, vii-viii. doi: 10.1016/j.otc.2004.02.004. Otolaryngol Clin North Am. 2004. PMID: 15262510 Review.
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.
Yamazaki T, Gunderson AJ, Gilchrist M, Whiteford M, Kiely MX, Hayman A, O'Brien D, Ahmad R, Manchio JV, Fox N, McCarty K, Phillips M, Brosnan E, Vaccaro G, Li R, Simon M, Bernstein E, McCormick M, Yamasaki L, Wu Y, Drokin A, Carnahan T, To Y, Redmond WL, Lee B, Louie J, Hansen E, Solhjem MC, Cramer J, Urba WJ, Gough MJ, Crittenden MR, Young KH. Yamazaki T, et al. Among authors: ahmad r. Lancet Oncol. 2022 Sep;23(9):1189-1200. doi: 10.1016/S1470-2045(22)00446-6. Epub 2022 Aug 8. Lancet Oncol. 2022. PMID: 35952709 Clinical Trial.
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Yamashita N, Morimoto Y, Fushimi A, Ahmad R, Bhattacharya A, Daimon T, Haratake N, Inoue Y, Ishikawa S, Yamamoto M, Hata T, Akiyoshi S, Hu Q, Liu T, Withers H, Liu S, Shapiro GI, Yoshizumi T, Long MD, Kufe D. Yamashita N, et al. Among authors: ahmad r. Mol Cancer Res. 2023 Mar 1;21(3):274-289. doi: 10.1158/1541-7786.MCR-22-0772. Mol Cancer Res. 2023. PMID: 36445328 Free PMC article.
82 results